Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 28, 2006. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically detailing changes in their interests in the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to specific equity transactions and does not contain consolidated financial statements.
Material Changes
The filing details the following specific transactions regarding director shareholdings on April 27, 2006:
- Mr. J S Heslop: Exercised options for 54,000 shares at GBP 11.79. Sold 46,665 shares at GBP 15.41 to cover costs and taxes. Net increase in holding: 7,335 shares (Total: 19,896.32 shares).
- Mrs. J Younger: Exercised options for 6,892 shares at GBP 12.75 and 45,000 shares at GBP 11.79. Sold 53,298 shares at an average price of GBP 15.21.
- Mr. R Bondy: Transferred 2,880 shares by gift.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of director share transactions.
Investor Verification Points
- Verify the total number of shares held by directors following the April 27, 2006 transactions.
- Confirm the exercise prices and sale prices utilized in the director transactions to assess potential insider trading patterns.
- Note that this filing does not reflect the company's overall financial performance for the period.